Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Exercise × 90 days × Clear all

Sponsor

Conditions

Motor Activity 20 Breast Neoplasms 11 Neoplasms 6 Obesity 3 Lymphoma, Follicular 3 Lymphedema 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Sarcopenia 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Brain Neoplasms 2 Skin Neoplasms 1 Recurrence 1 Psychological Well-Being 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Neurotoxicity Syndromes 1 Myeloproliferative Disorders 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Heart Failure 1 Head and Neck Neoplasms 1 Essential Hypertension 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 27 Nivolumab 26 cabozantinib 25 Magnetic Resonance Spectroscopy 19 Specimen Handling 16 Ipilimumab 16 lenvatinib 10 belzutifan 7 atezolizumab 7 Biopsy 7 Axitinib 7 Sunitinib 6 Everolimus 6 CTLA-4 Antigen 6 avelumab 5 aldesleukin 5 Radiosurgery 5 Immunoglobulin G 5 Bevacizumab 5 pazopanib 4 fludarabine 4 Disulfides 4 Cyclophosphamide 4 zimberelimab 3 palbociclib 3 cemiplimab 3 Radiotherapy 3 Nephrectomy 3 IFL protocol 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡